GBIM Insider Trading Activity and SEC Form 4 Filings
GBIM insider trading summary
No open-market insider purchases or sales of Globeimmune Inc (GBIM) have been reported on SEC Form 4 in the past 12 months.
Latest GBIM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 18, 2016 | Augustine Lawlor | Director | Sell | $17K (11,000 @ $1.55) |
| Mar 17, 2016 | Daniel J Mitchell | Director | Sell | $240 (158 @ $1.52) |
| Mar 17, 2016 | Daniel J Mitchell | Director | Sell | $19K (12,468 @ $1.52) |
| Mar 17, 2016 | S. Edward Torres | Director | Sell | $44K (26,188 @ $1.67) |
| Mar 16, 2016 | Daniel J Mitchell | Director | Sell | $207 (112 @ $1.85) |
| Mar 16, 2016 | Daniel J Mitchell | Director | Sell | $16K (8,862 @ $1.85) |
| Mar 15, 2016 | Daniel J Mitchell | Director | Sell | $1K (645 @ $2.17) |
| Mar 15, 2016 | Daniel J Mitchell | Director | Sell | $110K (50,831 @ $2.17) |
| Mar 15, 2016 | Augustine Lawlor | Director | Sell | $5K (2,500 @ $2.05) |
| Mar 11, 2016 | Augustine Lawlor | Director | Sell | $26K (16,300 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.